Found 5 matching trials
Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides
PHASE2This study evaluates the effectiveness - as judged by complete response - o...
Location
Multiple Locations
A-dmDT390-bisFv(UCHT1) Fusion Protein With Ionizing Radiation and Pembrolizumab for the Treatment of Stage IV Melanoma
PHASE1This study evaluates the effectiveness of adding a single four-day treatmen...
Location
James Graham Brown Cancer Center
A Study of VG712 in Patients With Mycosis Fungoides
PHASE2VG712 (A-dmDT390-bisFv(UCHT1) fusion protein) is a recombinant anti-CD3 imm...
Location
H. Lee Moffitt Cancer Center and Research Institute
A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL)
PHASE2This is a Phase II clinical trial aimed at treating a subgroup of patients ...
Location
Yale University School Of Medicine Recruiting
A-dmDT390-bisFv(UCHT1) Fusion Protein in Combination With Ionizing Radiation for Treatment of Stage IV Melanoma
PHASE1The purpose of this trial is to study A-dmDT390-bisFv(UCHT1) in combination...
Location
James Graham Brown Cancer Center